Cutaneous Disorders Related to Obesity

    January 2022 in “ Menoufia Medical Journal ”
    AlyaaA. A. Zahran, MohamedA Gaber
    TLDR Obesity can cause various skin problems, with differences in prevalence between males and females.
    The study "Cutaneous disorders related to obesity" conducted on 212 obese Egyptian patients from November 2020 to March 2021 concluded that obesity can lead to various skin complications. There were significant gender differences in the prevalence of acne, androgenic alopecia, atopic dermatitis, and psoriasis. Stretch marks were found in 81.6% of females and 87.7% of males, androgenic alopecia in 56.5% of females and 33.9% of males, acanthosis nigricans in 30.6% of females and 44.6% of males, and acne in 30.6% of females and 6.2% of males.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 4 months ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

      community Going to try and reverse MPB naturally.

      in Treatment  55 upvotes 2 years ago
      A user is trying to reverse male pattern baldness (MPB) naturally by taking high doses of Vitamin D, improving diet, exercising, reducing stress, and other lifestyle changes, but plans to use finasteride if no results are seen in 60 days. Other users are skeptical, advising medical treatments like finasteride and warning against potential vitamin D overdose and the ineffectiveness of natural remedies for genetic hair loss.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 4 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

      community Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China

      in Technology  14 upvotes 3 years ago
      The conversation discusses the approval of Kintor Pharmaceutical's AR-PROTAC (GT20029) for clinical trials in China for acne and androgenic alopecia. One user expresses optimism about new treatments being developed and seeks clarification on how the new drug works, specifically if it temporarily degrades the AR protein to reduce DHT sensitivity in hair follicles.

    Related Research

    1 / 1 results